Atorvastatin intra-subject Variability [Study As­sess­ment]

posted by nobody – 2017-09-27 12:11 (2782 d 14:55 ago) – Posting: # 17832
Views: 5,752

❝ Chance?

Maybe, but...

❝ Better assay?

No

❝ Design differences?

How?

❝ Lesser within-batch variability (-ies) than in the studies you compare to?

Variability has been attributed to various physiological sources, including e.g. liver function, transporter status:

https://www.ncbi.nlm.nih.gov/pubmed/22167570
https://www.ncbi.nlm.nih.gov/pubmed/21548957
https://www.ncbi.nlm.nih.gov/pubmed/20818835
—
Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
120 visitors (0 registered, 120 guests [including 8 identified bots]).
Forum time: 03:07 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5